In adenosine A2B knockouts acute treatment with inorganic nitrate improves glucose disposal, oxidative stress, and AMPK signaling in the liver
Open Access
- 7 August 2015
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 6, 222
Abstract
Rationale: Accumulating studies suggest that nitric oxide (NO) deficiency and oxidative stress are central pathological mechanisms in type 2 diabetes. Recent findings demonstrate therapeutic effects by boosting a nitrate-nitrite-NO pathway, an alternative pathway for NO formation. This study aimed at investigating the acute effects of inorganic nitrate on glucose and insulin signaling in adenosine A2B receptor knockout mice (A2B-/-), a genetic model of impaired metabolic regulation. Methods: Acute effects of nitrate treatment were investigated in aged wild-type (WT) and A2B-/- mice. One hour after injection with nitrate or placebo, metabolic regulation was evaluated by glucose and insulin tolerance tests. NADPH oxidase-mediated superoxide production and AMPK phosphorylation were measured in livers obtained from non-treated or glucose-treated mice, with or without prior nitrate injection. Plasma was used to determine insulin resistance (HOMA-IR) and NO signaling. Results: A2B-/- displayed increased body weight, reduced glucose clearance and attenuated overall insulin responses compared with age-matched WT. Nitrate treatment increased circulating levels of nitrate, nitrite and cGMP in A2B-/-, and improved glucose clearance. In WT mice, however, nitrate treatment did not influence glucose clearance. HOMA-IR increased following glucose injection in A2B-/-, but remained at basal levels in mice pretreated with nitrate. NADPH oxidase activity in livers from A2B-/-, but not WT mice, was reduced by nitrate. Livers from A2B-/- displayed reduced AMPK phosphorylation compared with WT mice, and this was increased by nitrate treatment. Injection with the anti-diabetic agent metformin induced similar therapeutic effects in the A2B-/- as observed with nitrate. Conclusion: The A2B-/- mouse is a genetic model of metabolic syndrome. Acute treatment with nitrate improved the metabolic profile, at least partly via reduction in oxidative stress and improved AMPK signaling in the liver.Keywords
This publication has 48 references indexed in Scilit:
- Adenosine receptors as drug targets — what are the challenges?Nature Reviews Drug Discovery, 2013
- L‐arginine or tempol supplementation improves renal and cardiovascular function in rats with reduced renal mass and chronic high salt intakeActa Physiologica, 2013
- The A2b Adenosine Receptor Modulates Glucose Homeostasis and ObesityPLOS ONE, 2012
- AMP-activated protein kinase, stress responses and cardiovascular diseasesClinical Science, 2012
- Contribution of oxidative stress to endothelial dysfunction in hypertensionFrontiers in Physiology, 2012
- Adenosine A2Areceptor activation attenuates tubuloglomerular feedback responses by stimulation of endothelial nitric oxide synthaseAmerican Journal of Physiology-Renal Physiology, 2011
- Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient miceProceedings of the National Academy of Sciences, 2010
- NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes?Biochemical Society Transactions, 2008
- Increased malonyl-CoA and diacylglycerol content and reduced AMPK activity accompany insulin resistance induced by glucose infusion in muscle and liver of ratsAmerican Journal of Physiology-Endocrinology and Metabolism, 2006
- Stimulators of AMP‐activated protein kinase inhibit the respiratory burst in human neutrophilsFEBS Letters, 2004